Class information for:
Level 1: TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1162 2712 47.9 94%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
169 21476 TRAIL//SURVIVIN//BCL 2

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 TRAIL Author keyword 805 54% 38% 1032
2 DR5 Author keyword 101 59% 4% 114
3 TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND Author keyword 92 63% 3% 92
4 TNF RELATED APOPTOSIS INDUCING LIGAND Author keyword 59 65% 2% 57
5 DEATH RECEPTOR 5 Author keyword 59 71% 2% 48
6 TRAIL RECEPTORS Author keyword 58 86% 1% 30
7 DR4 Author keyword 53 62% 2% 55
8 TRAIL RECEPTOR Author keyword 50 84% 1% 27
9 TRAIL RESISTANCE Author keyword 44 85% 1% 23
10 APO2L TRAIL Author keyword 42 70% 1% 35

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
LCSH search Wikipedia search
1 TRAIL 805 54% 38% 1032 Search TRAIL Search TRAIL
2 DR5 101 59% 4% 114 Search DR5 Search DR5
3 TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND 92 63% 3% 92 Search TUMOR+NECROSIS+FACTOR+RELATED+APOPTOSIS+INDUCING+LIGAND Search TUMOR+NECROSIS+FACTOR+RELATED+APOPTOSIS+INDUCING+LIGAND
4 TNF RELATED APOPTOSIS INDUCING LIGAND 59 65% 2% 57 Search TNF+RELATED+APOPTOSIS+INDUCING+LIGAND Search TNF+RELATED+APOPTOSIS+INDUCING+LIGAND
5 DEATH RECEPTOR 5 59 71% 2% 48 Search DEATH+RECEPTOR+5 Search DEATH+RECEPTOR+5
6 TRAIL RECEPTORS 58 86% 1% 30 Search TRAIL+RECEPTORS Search TRAIL+RECEPTORS
7 DR4 53 62% 2% 55 Search DR4 Search DR4
8 TRAIL RECEPTOR 50 84% 1% 27 Search TRAIL+RECEPTOR Search TRAIL+RECEPTOR
9 TRAIL RESISTANCE 44 85% 1% 23 Search TRAIL+RESISTANCE Search TRAIL+RESISTANCE
10 APO2L TRAIL 42 70% 1% 35 Search APO2L+TRAIL Search APO2L+TRAIL

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 DECOY RECEPTORS 405 75% 11% 296
2 APOPTOSIS INDUCING LIGAND 344 42% 23% 631
3 TRAIL INDUCED APOPTOSIS 253 39% 19% 513
4 APO2L TRAIL 208 80% 5% 129
5 LIGAND TRAIL 189 56% 9% 231
6 FADD DEPENDENT APOPTOSIS 179 73% 5% 136
7 CYTOTOXIC LIGAND TRAIL 125 66% 4% 117
8 DEATH RECEPTORS 118 37% 10% 258
9 DEATH RECEPTOR 5 112 75% 3% 81
10 APO2 LIGAND 111 80% 3% 70

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics 2013 61 93 73%
Targeting extrinsic apoptosis in cancer: Challenges and opportunities 2015 3 81 62%
The TRAIL apoptotic pathway in cancer onset, progression and therapy 2008 391 194 73%
Targeting apoptosis for anticancer therapy 2015 5 57 35%
Getting TRAIL back on track for cancer therapy 2014 24 152 51%
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) 2008 222 67 81%
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies 2012 50 71 77%
TRAIL receptor signalling and modulation: Are we on the right TRAIL? 2009 122 124 81%
Apo2L/TRAIL and its death and decoy receptors 2003 536 101 74%
Death receptors as targets in cancer 2013 29 133 78%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 OPTOSIS REGULAT 13 44% 0.8% 23
2 CELL SIGNALING OPTOSIS 13 62% 0.5% 13
3 HUMAN GENE THER Y UNIT 10 54% 0.5% 13
4 MORPHOL EMBRYOL 10 17% 2.0% 54
5 HUMAN NORMAL MORPHOL 9 67% 0.3% 8
6 MOL ONCOL CELL CYCLE REGULAT GENET 7 67% 0.2% 6
7 SURG PHARMACOL 6 31% 0.6% 17
8 PROGRAM GENE THER Y VIROL 6 50% 0.3% 9
9 MOL TARGETING CANC PREVENT 6 19% 1.0% 26
10 TRANSLAT ONCOL EXPT CANC THER EUT 5 37% 0.4% 11

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000141240 NECROPTOSIS//RIP3//NECROSTATIN 1
2 0.0000102156 CASP10//CASP8//CASPASE 10
3 0.0000091959 LIVIN//XIAP//SMAC MIMETICS
4 0.0000081671 OSTEOPROTEGERIN//VASC MED ATHEROTHROMBOSIS//INTERDEPARTMENTAL REGENERAT MED
5 0.0000069570 TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL
6 0.0000068216 FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
7 0.0000060230 BIKDD//MITOCHONDRIAL CYTOCHROME C RELEASE//BAX OVEREXPRESSION
8 0.0000057844 DCR3//DECOY RECEPTOR 3//TL1A
9 0.0000056470 PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR
10 0.0000050285 SFAS APO 1//ACUTE RELAPSE//AMYLOID PEPTIDE A BETA